Viking Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Viking Therapeutics Inc
TickerVKTX
CIK #0001607678
CUSIP92686J106
SectorLife Sciences - Pharmaceutical Preparations
Address4370 La Jolla Village Drive, Suite 400, La Jolla, CA 92122
Source [EDGAR]
CIK Filing 2011 - 2025
[0001607678] 10-K
[0001607678] 10-Q
[0001607678] 3
[0001607678] 4
[0001607678] 8-K
[0001607678] D
[0001607678] SC 13D
[0001607678] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
BlackRock Inc Viking Therapeutics Inc [2025-02-04] 0.0
Vanguard Group Inc Viking Therapeutics Inc [2024-02-13] 5.38
BlackRock Inc Viking Therapeutics Inc [2024-01-26] 7.6
Viking Global Investors LP Viking Therapeutics Inc [2023-11-02] 5.9
FMR LLC Viking Therapeutics Inc [2023-04-10] 0.0
Millennium Management LLC Viking Therapeutics Inc [2023-01-03] 6.3
BlackRock Inc Viking Therapeutics Inc [2022-07-08] 1.8
State Street Corp Viking Therapeutics Inc [2021-02-11] 6.95
ArrowMark Colorado Holdings LLC Viking Therapeutics Inc [2019-02-14] 5.31
State Street Corp Viking Therapeutics Inc [2019-02-13] 9.5
BlackRock Inc Viking Therapeutics Inc [2019-02-08] 5.7
FMR LLC Viking Therapeutics Inc [2018-10-10] 0.0
Boxer Capital LLC Viking Therapeutics Inc [2018-02-12] 0.0
Farwell Grosvenor Nicholas Viking Therapeutics Inc [2017-12-19] 7.8
Sphera Funds Management Ltd Viking Therapeutics Inc [2017-12-18] 7.43
Evans Daron Viking Therapeutics Inc [2017-02-17] 5.7
Dinerman Michael Viking Therapeutics Inc [2016-02-16] 6.1
LIAN Brian Viking Therapeutics Inc [2016-02-16] 15.2
Ligand Pharmaceuticals Inc Viking Therapeutics Inc [2015-05-08] 49.8
Form 3/4/5 Filer 2011 - 2025
Zante Greg
Viking Therapeutics, Inc.
Mancini Marianna
Lian Brian
Foehr Matthew W
Rouan Sarah Kathryn
Macartney Lawson
Rowland Charles A Jr
Singleton J Matthew
Morneau Michael
Ligand Pharmaceuticals Inc
Webster Stephen W
Masamune Hiroko
Hanley Rochelle
Dinerman Michael
Form 13F Holdings
Firm Period DFND Voting Shares
Vanguard Group Inc [2025-06-30] SOLE 0 9,992,251
FMR LLC [2025-06-30] DFND 9,742,737 9,821,897
Susquehanna International Group LLP [2025-06-30] OTR 2,066,651 5,706,951
BlackRock, Inc. [2025-06-30] SOLE 5,039,522 5,437,027
State Street Corp [2025-06-30] DFND 3,489,786 3,775,691
Morgan Stanley [2025-06-30] DFND 1,571,502 3,247,694
Citadel Advisors LLC [2025-06-30] DFND 2,760,875 2,760,875
JPMorgan Chase & Co [2025-06-30] DFND 2,422,352 2,638,602
Balyasny Asset Management LP [2025-06-30] SOLE 2,371,300 2,371,300
Geode Capital Management LLC [2025-06-30] DFND 1,923,305 1,923,305
Pictet Asset Management Holding SA [2025-06-30] SOLE 1,717,711 1,916,874
Norges Bank [2025-06-30] SOLE 1,767,777 1,767,777
Ameriprise Financial Inc [2025-06-30] DFND 0 1,476,314
Braidwell LP [2025-06-30] SOLE 1,437,555 1,437,555
Jane Street Group LLC [2025-06-30] DFND 825,774 1,332,074
Two Sigma Investments LP [2025-06-30] SOLE 1,313,783 1,313,783
Millennium Management LLC [2025-06-30] SOLE 941,937 1,110,137
Two Sigma Advisers LP [2025-06-30] SOLE 1,058,028 1,091,428
UBS Group AG [2025-06-30] DFND 884,136 951,527
Citigroup Inc [2025-06-30] DFND 864,111 864,111
Raymond James Financial Inc [2025-06-30] DFND 104,466 822,278
Charles Schwab Investment Management Inc [2025-06-30] SOLE 727,419 727,420
Frontier Capital Management Co LLC [2025-06-30] SOLE 312,242 638,204
Clearbridge Investments LLC [2025-06-30] SOLE 631,301 631,353
Royal Bank of Canada [2025-06-30] DFND 599,566 602,584
Cubist Systematic Strategies, LLC [2025-06-30] DFND 0 596,650
Principal Financial Group Inc [2025-06-30] DFND 565,066 565,066
Duquesne Family Office LLC [2025-06-30] DFND 549,295 549,295
Northern Trust Corp [2025-06-30] DFND 540,830 541,583
Bank of America Corp /DE/ [2025-06-30] DFND 9,881 524,772
Prev | Page 2 | Next
Terms | Privacy | Guide
tony@aum13f.com